The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Greg Ellwood-Hughes, Senior Policy and Public Affairs Officer at The Royal College of Ophthalmologists, explores how AI is supporting ophthalmology services and the issues to be addressed in the coming years to realise its full potential.
Simone Biscaglia, European Society of Cardiology Member, states the case here for what could be the next (cheap) medical revolution, “reasonable” physical activity for all.
Prof Filippo Graziani, President of the European Federation of Periodontology (EFP), turns the spotlight on periodontitis and answers if gum disease increases the risk of hypertension, heart attack and stroke.
Professor Adrian Wilson, MBBS, BSc (Hons), FRCS, FRCS Tr & Orth Specialist Knee Surgeon (Professor), tells us what we need to know about exciting new regenerative treatments that take centre stage for knees in the world of orthobiologics.
Dr Suresh Kuppuswamy, Industry Principal – Healthcare at Frost & Sullivan, explores the future of medical imaging, focussing on Radiology-as-a-Service.
Marco Marsella, Head of Unit, Directorate-General Communications Network, Content and Technology (DG Connect), European Commission, speaks to OAG about AI and digital transformation in healthcare.
Brian Jones, Chief Executive at Partnership of East London Co-operatives, shares his thoughts on procurement frameworks in the NHS including the GP Futures Framework.
Emily Y. Chew, M.D., Director of the Division of Epidemiology and Clinical Applications and the Deputy Clinical Director at the National Eye Institute, part of the National Institutes of Health, examines why early detection is crucial to prevent blindness from diabetic retinopathy.
Jane Kinghorn, Director at UCL Translational Research Office and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.
The work of the National Institute of Mental Health (NIMH) in the U.S. is charted here, which we find out is the largest research organisation for mental illness in the world.
Dr Nobuhiko Hayashi from The Fetal Medicine Foundation Japan, underlines the importance of improving the health of pregnant women and their babies through fetal medicine research and training.
